Tag: Japan
Exclude medical devices from the list of India-EU Free Trade Agreement...
India already dependent on imports of medical devices to the tune of 70% presently
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization...
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI
OPPI welcomes Indian govt’s move to waive off local clinical trials...
This will be applicable to a few select drugs already approved in well-regulated markets like the USA, UK, Japan, Australia, Canada, and the EU
Oncology tests market in Japan to reach $30 million by 2033,...
High cancer incidence, driven by dietary habits and smoking, propels demand for advanced diagnostic technologies, with Japan leading the Asia-Pacific market in 2024
Intracellular protein delivery using hybrid nanotubes could revolutionize cancer treatment
The hybrid nanotube stamp system revolutionizes precision medicine with high efficiency and cell viability rates for cancer treatment
Takeda oncology pipeline remains robust despite shift in focus from CAR-T...
Despite these adjustments, the Japan-based pharma major's oncology pipeline remains robust, says GlobalData
Cipla enters into JV with Kemwell Biopharma & Manipal Education &...
The primary goal of this joint venture is to develop and commercialize novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Biocon Biologics concludes integration of acquired biosimilars business in 120 countries
Over 10 Emerging Markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris.
Meril Life Sciences inks pact with Japan Lifeline for promoting its...
This strategic alliance empowers Japan Lifeline to promote Meril’s next generation transcatheter heart valve, Myval Octacor, upon PMDA approval in Japan